Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC
N/A
18 Years
88 Years
18 Years
88 Years
Not Enrolling
Both
Adjuvant, Chemotherapy, Lung, Cancers
Both
Adjuvant, Chemotherapy, Lung, Cancers
Trial Information
Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC
We propose to retrospectively examine the Washington University School of Medicine
experience on all patients receiving adjuvant chemotherapy between 2003 and 2005. We will
retrospectively analyze the survival and outcomes in the lung cancer patients receiving
adjuvant chemotherapy following surgical resection.
Inclusion Criteria:
- Patients that received adjuvant chemotherapy
- 18-88 years
Exclusion Criteria:
- Any patients that have not received adjuvant chemotherapy
- Patients under 18 or over 88
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Principal Investigator
Ramaswamy Govindan, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Washington University School of Medicine
Authority:
United States: Institutional Review Board
Study ID:
06-0155
NCT ID:
NCT00484016
Start Date:
February 2006
Completion Date:
April 2007
Related Keywords:
- Adjuvant
- Chemotherapy
- Lung
- Cancers
- adjuvant
- chemotherapy
- observation
- resected
- cancers
Name | Location |
|---|
